688235 百济神州
交易中 03-13 10:54:33
资讯
新帖
简况
百济神州：合共5.7万股美国存托股份获购买
智通财经 · 03-12 23:32
百济神州：合共5.7万股美国存托股份获购买
百济神州(06160)根据股份计划发行74.13万股
智通财经 · 03-12 07:44
百济神州(06160)根据股份计划发行74.13万股
百济神州（688235）披露港股审计委员会将审议2025年全年业绩，3月11日股价下跌2.9%
证券之星 · 03-11 22:10
百济神州（688235）披露港股审计委员会将审议2025年全年业绩，3月11日股价下跌2.9%
科创板成长层首批“退层”企业出炉！百济神州、寒武纪等在列
东方财富网 · 03-11 16:40
科创板成长层首批“退层”企业出炉！百济神州、寒武纪等在列
百济神州(06160)：2018 员工购股计划的新一轮认购期自3月2日起至8月31日止
智通财经 · 03-10 16:53
百济神州(06160)：2018 员工购股计划的新一轮认购期自3月2日起至8月31日止
百济神州涨5.29%，浦银国际证券一日前给出“买入”评级，目前股价已超目标价
证券之星 · 03-10 16:21
百济神州涨5.29%，浦银国际证券一日前给出“买入”评级，目前股价已超目标价
营收382亿！创新药“一哥”百济神州，全面扭亏
蓝鲸财经 · 03-09
营收382亿！创新药“一哥”百济神州，全面扭亏
百济神州授出合共2.12万股美国存托股份受限制股份单位
新浪港股 · 03-08
百济神州授出合共2.12万股美国存托股份受限制股份单位
每周股票复盘：百济神州（688235）2025年自由现金流为正
证券之星 · 03-08
每周股票复盘：百济神州（688235）2025年自由现金流为正
百济神州(06160)授出合共2.12万股美国存托股份受限制股份单位
智通财经 · 03-06
百济神州(06160)授出合共2.12万股美国存托股份受限制股份单位
首批！“调出”科创板成长层，涉寒武纪、百济神州等
券商中国 · 03-06
首批！“调出”科创板成长层，涉寒武纪、百济神州等
首次全年盈利，百济神州为何股价三地齐跌？
中国新闻网 · 03-03
首次全年盈利，百济神州为何股价三地齐跌？
交银国际：百济神州(06160)上季产品销售强势 维持“买入”评级
智通财经 · 03-03
交银国际：百济神州(06160)上季产品销售强势 维持“买入”评级
国金证券：维持百济神州(06160)“买入”评级 早研管线步入收获期
智通财经 · 03-03
国金证券：维持百济神州(06160)“买入”评级 早研管线步入收获期
【机构调研记录】摩根士丹利基金调研百济神州
证券之星 · 03-03
【机构调研记录】摩根士丹利基金调研百济神州
【机构调研记录】工银瑞信基金调研维尔利、百济神州
证券之星 · 03-03
【机构调研记录】工银瑞信基金调研维尔利、百济神州
【机构调研记录】光大保德信基金调研百济神州、虹软科技
证券之星 · 03-03
【机构调研记录】光大保德信基金调研百济神州、虹软科技
【券商聚焦】交银国际维持百济神州(06160)买入评级 指4Q25产品销售强势
金吾财讯 · 03-02
【券商聚焦】交银国际维持百济神州(06160)买入评级 指4Q25产品销售强势
首次实现全年盈利 百济神州2025年营收增长超四成
经济参考报 · 03-02
首次实现全年盈利 百济神州2025年营收增长超四成
每周股票复盘：百济神州（688235）2025年净利14.22亿同比增128.57%
证券之星 · 03-01
每周股票复盘：百济神州（688235）2025年净利14.22亿同比增128.57%
公司概况
公司名称：
百济神州有限公司
所属行业：
医药制造业
上市日期：
2021-12-15
主营业务：
百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。
发行价格：
192.60
{"stockData":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":229.23,"timestamp":1773370473000,"preClose":233.84,"halted":0,"volume":1749482,"delay":0,"changeRate":-0.0197,"floatShares":114999999,"shares":1541000000,"eps":-0.0993,"marketStatus":"交易中","change":-4.61,"latestTime":"03-13 10:54:33","open":231.31,"high":231.82,"low":227,"amount":401000000,"amplitude":0.0206,"askPrice":229.57,"askSize":2,"bidPrice":229.23,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.0993,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1773372600000},"marketStatusCode":2,"adr":0,"adjPreClose":233.84,"symbolType":"stock_kcb","openAndCloseTimeList":[[1773365400000,1773372600000],[1773378000000,1773385200000]],"highLimit":257.22,"lowLimit":210.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1541419108,"isCdr":false,"pbRate":12.29,"roa":"--","roe":"4.26%","epsLYR":-3.64,"committee":0.304348,"marketValue":353340000000,"turnoverRate":0.0152,"status":1,"hkstockBrief":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":172.8,"timestamp":1773370461876,"preClose":176.2,"halted":0,"volume":1310900,"delay":0,"premium":"-33.66"},"floatMarketCap":26374000000},"requestUrl":"/m/hq/s/688235/wiki","defaultTab":"wiki","newsList":[{"id":"2618158480","title":"百济神州：合共5.7万股美国存托股份获购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2618158480","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618158480?lang=zh_cn&edition=full","pubTime":"2026-03-12 23:32","pubTimestamp":1773329520,"startTime":"0","endTime":"0","summary":"百济神州(06160)发布公告，截至2025年9月2日至2026年2月27日之认购期的最后一日，合共5.7万股美国存托股份由4431名参与者根据2018员工购股计划购买。所购美国存托股份涉及的股份数目为74.13 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260312/c675259016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688235","BK0239"],"gpt_icon":0},{"id":"2618972362","title":"百济神州(06160)根据股份计划发行74.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618972362","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618972362?lang=zh_cn&edition=full","pubTime":"2026-03-12 07:44","pubTimestamp":1773272679,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月11日根据股份计划发行74.13万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1583","BK1500","BK1161","BK0239","BK4526","BK4139","688235","LU1770034418.SGD","BK4588","LU1719994722.HKD","LU2328871848.SGD","06160","LU1303224171.USD","LU1251922891.USD","LU1969619763.USD","LU0588546209.SGD","BK1588","ONC","LU0307460666.USD"],"gpt_icon":0},{"id":"2618231069","title":"百济神州（688235）披露港股审计委员会将审议2025年全年业绩，3月11日股价下跌2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618231069","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618231069?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:10","pubTimestamp":1773238231,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，百济神州报收于238.09元，较前一交易日下跌2.9%，最新总市值为3668.2亿元。近日，百济神州有限公司发布港股公告显示，公司董事会审计委员会将于2026年3月25日审议及批准公司及其附属公司截至2025年12月31日止全年业绩，并根据香港上市规则刊发全年业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0588546209.SGD","BK1500","LU1770034418.SGD","BK0239","LU2328871848.SGD","LU1719994722.HKD","LU0307460666.USD","LU1969619763.USD","BK1583","BK1588","LU1251922891.USD","LU1303224171.USD","06160","688235","BK1161"],"gpt_icon":0},{"id":"2618917443","title":"科创板成长层首批“退层”企业出炉！百济神州、寒武纪等在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917443","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917443?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:40","pubTimestamp":1773218438,"startTime":"0","endTime":"0","summary":"据统计，截至3月11日，科创板全体公司均以业绩快报或预告形式完成对2025年经营情况的披露，预计将实现营业收入1.59万亿元，同比增长10.3%；净利润591亿元，同比增长28.2%。随着业绩的集中披露，科创板成长层也将迎来首批“退层”公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1345,202603113668838022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LU1251922891.USD","LU2476274720.SGD","LU1770034418.SGD","LU0307460666.USD","BK0239","SG9999003461.SGD","BK4585","06160","ONC","SG9999006597.SGD","SGXZ90724238.SGD","BK1500","LU2778985437.USD","LU2476274308.USD","688235","BK1161","BK4526","SG9999001051.SGD","SG9999001069.SGD","SGXZ49509284.SGD","SG9999002950.SGD","LU1719994722.HKD","LU2328871848.SGD","BK1583","BK4139","LU0588546209.SGD","SG9999001093.SGD","BK0231","BK1588","LU1969619763.USD","159982","LU1303224171.USD","SGXZ81163826.USD","688256","BK4588"],"gpt_icon":0},{"id":"2618293810","title":"百济神州(06160)：2018 员工购股计划的新一轮认购期自3月2日起至8月31日止","url":"https://stock-news.laohu8.com/highlight/detail?id=2618293810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618293810?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:53","pubTimestamp":1773132798,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2018 员工购股计划的新一轮认购期自2026年3月2日起至2026年8月31日止。2018员工购股计划使合资格雇员可按市价15%折让申购股份。雇员可于认购期结束后购买股份，购股资金可从其认购期内所得薪金中扣除。本公司相信，持续为本公司雇员提供通过参与2018员工购股计划获得本公司所有权权益的机会，鼓励其继续受雇于本公司，并使其利益与本公司股东的利益更紧密地保持一致，符合本公司及股东的最佳利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","BK1583","LU1719994722.HKD","BK0239","LU1770034418.SGD","LU1251922891.USD","BK4588","LU0307460666.USD","BK1500","LU1969619763.USD","06160","BK4139","LU1303224171.USD","688235","LU2328871848.SGD","BK4526","BK4585","BK1161","BK1588","ONC"],"gpt_icon":0},{"id":"2618536980","title":"百济神州涨5.29%，浦银国际证券一日前给出“买入”评级，目前股价已超目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2618536980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618536980?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:21","pubTimestamp":1773130864,"startTime":"0","endTime":"0","summary":"今日百济神州涨5.29%，收盘报245.2元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，现价已超分析师预估，涨幅达到3.90%。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为12.74%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的甘坛焕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","06160","688235"],"gpt_icon":0},{"id":"2618009613","title":"营收382亿！创新药“一哥”百济神州，全面扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2618009613","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618009613?lang=zh_cn&edition=full","pubTime":"2026-03-09 10:37","pubTimestamp":1773023833,"startTime":"0","endTime":"0","summary":"2月26日晚，百济神州发布2025年业绩快报。然而，面对业绩全面扭亏，市场反应冷淡。财报发布后，百济神州美股两个交易日跌幅超10%。业绩快报显示，百济神州产品收入377.70亿元，同比增长39.9%，主要由百悦泽、安进授权产品及百泽安销售增长驱动。具体来看，2025年百悦泽全球销售额280.67亿元，同比增长48.8%，创历史新高；百泽安全球销售额52.97亿元，同比增长18.6%。随着适应症持续拓展，百济神州已具备头部药企竞争力。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1772409403580961090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","159992","06160","688235","ONC"],"gpt_icon":0},{"id":"2617666539","title":"百济神州授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617666539","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617666539?lang=zh_cn&edition=full","pubTime":"2026-03-08 10:31","pubTimestamp":1772937060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 百济神州（06160）发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-08/doc-inhqfsut4635660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1719994722.HKD","BK4139","BK4585","LU1770034418.SGD","BK1161","LU2328871848.SGD","LU1251922891.USD","06160","BK4526","LU0588546209.SGD","BK1500","BK1588","BK4588","LU1303224171.USD","BK0239","BK1583","LU1969619763.USD","ONC","LU0307460666.USD","688235"],"gpt_icon":0},{"id":"2617668912","title":"每周股票复盘：百济神州（688235）2025年自由现金流为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668912","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617668912?lang=zh_cn&edition=full","pubTime":"2026-03-08 01:21","pubTimestamp":1772904070,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，百济神州报收于238.49元，较上周的257.7元下跌7.45%。本周，百济神州3月2日盘中最高价报259.2元。2025财年首次实现GP净利润和非GP净利润，经营活动产生的净现金为11亿美元，自由现金流为正。计划参与2026年国家医保谈判。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","LU0588546209.SGD","LU1770034418.SGD","BK1588","BK1500","LU0307460666.USD","LU1303224171.USD","LU1719994722.HKD","159201","LU1969619763.USD","LU2328871848.SGD","06160","LU1251922891.USD","688235","BK1583"],"gpt_icon":0},{"id":"2617068639","title":"百济神州(06160)授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617068639","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617068639?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:20","pubTimestamp":1772788807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1251922891.USD","BK4585","LU0307460666.USD","06160","LU1303224171.USD","LU1770034418.SGD","ONC","BK0239","LU0588546209.SGD","BK4588","LU1969619763.USD","BK4139","BK1588","LU1719994722.HKD","LU2328871848.SGD","688235","BK1161","BK1583","BK4526","BK1500"],"gpt_icon":0},{"id":"2617501282","title":"首批！“调出”科创板成长层，涉寒武纪、百济神州等","url":"https://stock-news.laohu8.com/highlight/detail?id=2617501282","media":"券商中国","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617501282?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:01","pubTimestamp":1772758860,"startTime":"0","endTime":"0","summary":"近日，多家科创板成长层企业发布了2025年度业绩快报。包括寒武纪、百济神州等在内的企业纷纷扭亏为盈。根据科创板成长层的相关规则，上述企业预计将在年报正式披露后摘除特殊标识，退出科创板成长层。据悉，科创板成长层于去年6月份推出，这将是首批“退层”企业。公司应当在披露年度报告的同时，披露符合条件且将被调出科创成长层的公告。这4家在年报正式披露后或也将被调出科创成长层。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3NjM5MjIwOQ==&mid=2652257320&idx=2&sn=1a30f506242618baaaeaa39a9f05819f&chksm=85508ad42695f69dd234ae51d881f82448e6fb0665374c5f128426719f4897d8619a637188ae&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["06160","BK1588","BK4139","BK0239","SGXZ81163826.USD","LU0588546209.SGD","LU0307460666.USD","LU2476274308.USD","LU1303224171.USD","BK1500","688256","BK4588","SG9999001093.SGD","SG9999001051.SGD","SGXZ49509284.SGD","159982","BK4585","688235","BK0231","LU2476274720.SGD","SG9999001069.SGD","LU2328871848.SGD","LU2778985437.USD","LU1719994722.HKD","BK4526","LU1770034418.SGD","LU1251922891.USD","BK1161","SG9999003461.SGD","SG9999006597.SGD","SGXZ90724238.SGD","SG9999002950.SGD","ONC","BK1583","LU1969619763.USD"],"gpt_icon":1},{"id":"2616297723","title":"首次全年盈利，百济神州为何股价三地齐跌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2616297723","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616297723?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:49","pubTimestamp":1772549340,"startTime":"0","endTime":"0","summary":"中新网北京3月3日电(记者赵方园)一度被冠以“烧钱一哥”的A股创新药龙头百济神州，终于在2025年迎来了历史性转折。近期，百济神州发布2025年度业绩快报，报告期内实现营业总收入382.05亿元，同比增长40.4%；归属于上市公司股东的净利润14.22亿元。而在2024年同期，公司亏损49.78亿元。这是百济神州成立十六年以来首次实现全年盈利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603033660707240.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603033660707240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1719994722.HKD","688235","LU1770034418.SGD","BK1583","LU1303224171.USD","BK4526","BK4585","LU1251922891.USD","BK1500","BK4588","ONC","LU0588546209.SGD","BK1161","LU2328871848.SGD","BK0239","LU1969619763.USD","LU0307460666.USD","BK4139","BK1588","06160"],"gpt_icon":0},{"id":"2616316707","title":"交银国际：百济神州(06160)上季产品销售强势 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316707","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616316707?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:09","pubTimestamp":1772521742,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，百济神州去年第四季泽布替尼销售额11亿美元(下同)，同比及按季分别升38%及10%，美国销售额8.45亿，同比及按季分别升37%及14%。在1LCLL患者中，泽布在BTK品类中的份额约占一半、在所有治疗药物中约占四分之一。公司指引2026年收入62亿至64亿，GAAP经营费用47亿至49亿元，毛利率在80%区间的高位，non-GAAP净利润14亿至15亿元，维持“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","06160","688235"],"gpt_icon":0},{"id":"2616783391","title":"国金证券：维持百济神州(06160)“买入”评级 早研管线步入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2616783391","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616783391?lang=zh_cn&edition=full","pubTime":"2026-03-03 10:36","pubTimestamp":1772505397,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，维持百济神州“买入”评级。公司核心产品高速放量，研发管线有望迎来密集催化。国金证券主要观点如下：业绩简评2026年2月26日公司发布2025年业绩快报，全年实现总收入53亿美元，实现GAAP净利润2.87亿美元;其中25Q4实现总收入15亿美元，实现GAAP净利润6650万美元。风险提示商业化进展不及预期风险、市场竞争加剧风险、临床试验进展不及预期风险、产品上市审评进展不及预期风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","ONC","688235"],"gpt_icon":0},{"id":"2616360737","title":"【机构调研记录】摩根士丹利基金调研百济神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616360737?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:10","pubTimestamp":1772496658,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及3月2日披露的机构调研信息，摩根士丹利基金近期对1家上市公司进行了调研，相关名单如下：1）百济神州 调研纪要：公司在2025年实现净利润和正向自由现金流，经营活动净现金达11亿美元，自由现金流为正。摩根士丹利基金成立于2003年，截至目前，资产管理规模335.08亿元，排名102/212；资产管理规模335.06亿元，排名90/212；管理公募基金数70只，排名88/212；旗下公募基金经理13人，排名95/212。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300006402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1770034418.SGD","688235","BK1161","LU1303224171.USD","LU0588546209.SGD","06160","BK1588","BK1583","LU2328871848.SGD","BK0239","BK1500","LU1251922891.USD","LU1969619763.USD","LU0307460666.USD","LU1719994722.HKD"],"gpt_icon":0},{"id":"2616360223","title":"【机构调研记录】工银瑞信基金调研维尔利、百济神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616360223?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:10","pubTimestamp":1772496653,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及3月2日披露的机构调研信息，工银瑞信基金近期对2家上市公司进行了调研，相关名单如下：1）维尔利 调研纪要：公司加快推动以科技为核心动力，助力生物能源和工业服务为核心的战略转型。2）百济神州 调研纪要：公司在2025年实现净利润和正向自由现金流，经营活动净现金达11亿美元，自由现金流为正。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300006395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0077","688235","LU1770034418.SGD","BK1500","LU1719994722.HKD","LU1303224171.USD","BK0150","BK0135","300190","BK1583","LU1969619763.USD","LU1251922891.USD","BK0218","LU2328871848.SGD","LU0307460666.USD","BK1588","LU0588546209.SGD","06160","BK0239"],"gpt_icon":0},{"id":"2616360201","title":"【机构调研记录】光大保德信基金调研百济神州、虹软科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616360201?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:10","pubTimestamp":1772496633,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及3月2日披露的机构调研信息，光大保德信基金近期对2家上市公司进行了调研，相关名单如下：1）百济神州 调研纪要：公司在2025年实现净利润和正向自由现金流，经营活动净现金达11亿美元，自由现金流为正。2）虹软科技 调研纪要：存储涨价会倒逼行业转向价值战，提升高端机型占比，虹软可发挥软件优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300006368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU1770034418.SGD","LU0307460666.USD","BK1588","06160","688235","BK1583","LU2328871848.SGD","LU0588546209.SGD","LU1251922891.USD","BK1500","LU1303224171.USD","BK0231","LU1969619763.USD","BK0239","688088","LU1719994722.HKD"],"gpt_icon":0},{"id":"2616056538","title":"【券商聚焦】交银国际维持百济神州(06160)买入评级 指4Q25产品销售强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2616056538","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616056538?lang=zh_cn&edition=full","pubTime":"2026-03-02 10:13","pubTimestamp":1772417607,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，百济神州 4Q25泽布替尼销售额11亿，同/环比+38%/+10%，美国销售额8.45亿。在1LCLL患者中，泽布在BTK品类中的份额约占一半、在所有治疗药物中约占1/4。4Q25毛利率同比提升4.7ppts至90.5%，SG&A费用率同比下降7.7ppts，non-GAAP净利润同比大增至2.25亿。公司指引2026年收入62-64亿，GAAP经营费用4749亿，毛利率在80%区间的高位，non-GAAP净利润14-15亿。泽布+索托固定周期疗法首个同机制对照III期近期已启动。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975682","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","688235","06160"],"gpt_icon":0},{"id":"2616871468","title":"首次实现全年盈利 百济神州2025年营收增长超四成","url":"https://stock-news.laohu8.com/highlight/detail?id=2616871468","media":"经济参考报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616871468?lang=zh_cn&edition=full","pubTime":"2026-03-02 04:50","pubTimestamp":1772398248,"startTime":"0","endTime":"0","summary":"近日，创新药龙头百济神州（688235.SH/06160.HK）发布的2025年度业绩快报显示，公司全年实现营业总收入382.05亿元，同比大幅增长40.4%；实现归属于母公司所有者的净利润达14.22亿元，较上年同期的净亏损49.78亿元实现扭亏为盈。这是百济神州首次实现年度盈利，或标志着这家创新药企迈入可持续盈利的新发展阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603023657828489.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603023657828489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"gpt_icon":0},{"id":"2616284869","title":"每周股票复盘：百济神州（688235）2025年净利14.22亿同比增128.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616284869","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616284869?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:16","pubTimestamp":1772298972,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，百济神州报收于257.7元，较上周的279.62元下跌7.84%。本周关注点业绩披露要点：百济神州2025年归属净利润14.22亿元，同比增长128.57%。公司公告汇总：百济神州完成注册地变更，自2025年5月27日起受瑞士法律管辖。公司公告汇总百济神州发布2025年度业绩快报，营业总收入382.05亿元，同比增长40.4%；归属于母公司所有者的净利润14.22亿元，实现扭亏为盈。百悦泽全球销售额280.67亿元，同比增长48.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688235","06160","BK1588","LU0307460666.USD","BK0239","BK1583","LU1719994722.HKD","LU1770034418.SGD","LU2328871848.SGD","LU0588546209.SGD","BK1500","LU1969619763.USD","LU1251922891.USD","LU1303224171.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773370478749,"stockEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.1824},{"period":"3month","weight":-0.1543},{"period":"6month","weight":-0.259},{"period":"1year","weight":0.0811},{"period":"ytd","weight":-0.1294}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0002},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.0668},{"period":"1year","weight":0.2246},{"period":"ytd","weight":0.0404}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"百济神州有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36008人(较上一季度增加55.74%)","perCapita":"3195股","listingDate":"2021-12-15","address":"c/oBeOneMedicinesIGmbH,Aeschengraben27,4051Basel,Switzerland","registeredCapital":"15万元","survey":" 百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。","listedPrice":192.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,688235,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}